Skip to main content
. 2017 May 22;50(2):461–473. doi: 10.4143/crt.2017.104

Fig. 6.

Fig. 6.

Validation with microarray data from 26 ovarian cancer samples from Samsung Medical Center. (A) Hierarchical clustering of gene expression according to lymphatic invasion. (B) Prediction accuracy of magnetic resonance imaging (MRI), molecular signature, and combination. (C, D) Random survival forest model showing incorporating molecular data and clinical variables improved the prediction of progression-free survival and overall survival.